Auddia Inc. (NASDAQ: AUUD) today spotlighted Influence Healthcare, a healthtech platform that leverages artificial intelligence and vertical integration to enable surgeons to lead value-based care (VBC) in high-spend specialties. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission later this week, a key step in the merger process that will combine Auddia with Thramann Holdings LLC, which fully owns Influence Healthcare, LT350, and Voyex.
Influence Healthcare is designed as a structural alternative to traditional hospital employment and private-equity rollups, aiming to restore physician leadership and reduce administrative burdens. The platform organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in specialties such as spine and total joint surgery. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, and supply chain logistics, allowing surgeons to focus on clinical care.
“Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care,” said Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare. “Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price.”
The model is built on the premise that physicians deliver value and should therefore lead the system. Influence Healthcare creates surgeon-led enterprises where surgeons retain governance authority, episode-based economics flow to clinicians, and facilities participate through aligned partnerships rather than ownership. AI reduces overhead by automating administrative tasks that have historically required multiple full-time staff per surgeon, contributing to burnout and inefficiency.
Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney, the combined entity to be named after the merger closes. The platform will deploy agentic-AI workflows to automate clinical documentation, coding, billing preparation, prior-authorization, and care-pathway monitoring. “AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said.
Influence Healthcare’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs. The company aims to deliver lower total cost of care, improved outcomes, reduced administrative overhead, and restored autonomy for surgeons. For more information, visit www.influencehealthcare.com.
The merger, announced on February 17, 2026, will result in Auddia changing its name to McCarthy Finney and trading under the ticker MCFN. McCarthy Finney will operate as an AI holding company delivering AI and Web3 services to its portfolio companies, including LT350, a distributed AI data center company; Voyex, a travel services platform; and the legacy Auddia audio business.
